Triumeq
2 Novel HIV Drugs Look Promising
ViiV Healthcare reported interim results for two investigational HIV medications—both look promising.
NOVEMBER 15, 2018
FDA Warns of Neural Tube Birth Defects With Dolutegravir
The FDA issued an alert about serious cases of neural tube birth defects involving the brain, spine and spinal cord ...
MAY 18, 2018
Switching HIV Regimen Found Safe
Switching to the newly approved Biktarvy in virologically suppressed adults maintained viral suppression with fewer ...
MARCH 7, 2018
Bictegravir-Containing Compound Found Noninferior in Phase 3 Trial
Bictegravir is a novel, potent integrase strand transfer inhibitor (INSTI), which features a high in vitro barrier ...
OCTOBER 10, 2017
Load more